Delivery Order SPE2DB24D2105-SPE2DB24FAPSY

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a $1,268.31 firm fixed price delivery order for the supply of XTAMPZA ER 36 MG capsules. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 and running through...
This federal contract award, valued at $3,104.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.60 Firm Fixed Price Delivery Order contract is for the supply of XTAMPZA ER 13.5 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,706.55 firm fixed-price delivery order is for the supply of XTAMPZA ER 27 MG capsules in 100-count bottles. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award to AmerisourceBergen Drug Corp. is for the delivery of Xtampza ER 18 mg capsules in 100-count bottles. The $1,481.82 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of August 28, 2024. This appears to be a delivery order issued under one of AmerisourceBergen's larger Indefinite Delivery Contracts with DLA Troop Support Medical or the Department of Justice Federal...
This federal contract award, valued at $12,002.43, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a firm fixed-price delivery order for the supply of Xtampza ER Capsules 18mg, a medication used for pain management. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,122.80 Firm Fixed Price delivery order is for XTAMPZA ER CAPS 13.5MG, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,440.95 firm fixed-price delivery order is for the supply of the prescription medication Xtampza ER Capsules 18mg. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,268.31 firm fixed price delivery order is for the supply of the medication XTAMPZA ER 36 MG CAPSULE 100S. Amerisourcebergen Drug Corp holds a single award indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a $2,239.69 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xtampza ER 9 mg capsules. The contract has a completion date of July 30, 2024 and was awarded on July 29, 2024. The contract is not set aside for any specific business designation. As a key supplier to federal healthcare programs, AmerisourceBergen leverages its extensive pharmaceutical supply chain to provide a...
  • SPE2DB24D2105
    Indefinite Delivery Contract
  • SPE2DB24D2105-SPE2DB24FAPSY
    Delivery Order

This federal contract award, valued at $1,605.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order to provide 100 count bottles of the prescription medication Xtampza ER 18 mg capsules. The contract has an ultimate completion date of August 1, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to supply a wide range of pharmaceutical and medical products, including specialty medications, generic drugs, and critical care supplies. These IDCs enable government agencies to efficiently procure essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation.

Generated 10/30/24, 9:36 AM